pre-seed
Stage
1
Investors
About
Unlocked Labs develops probiotics with activated/dormant genes that uptake and break down specific compounds in the gastrointestinal tract to lower systemic levels of waste toxins (e.g., urate and oxalate). The company pursues GRAS/medical-food regulatory routes to bring consumer-facing microbiome products to market before initiating clinical drug trials.
Explore Unlocked Labs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.